# CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

> **NCT01905475** · PHASE2 · COMPLETED · sponsor: **Polyphor Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Large Reperfused ST-Elevation Myocardial Infarction

## Interventions

- **DRUG:** POL6326
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01905475
- **Lead sponsor:** Polyphor Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-10
- **Final completion:** 2016-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905475, "CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01905475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*